The importance of Cat S and PPARγ in the development of SLE associated with PAH was proven by experiments using the selective Cat S inhibitor Millipore-219393, which upregulated PPARγ and suppressed Cat S expression to prevent pulmonary arterial remodeling and right ventricular hypertrophy in experimental SLE. This evidence concerns the gene PPARG and systemic lupus erythematosus.